Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Total 13F shares
-
73,531,027
-
Share change
-
-92,011
-
Total reported value
-
$20,397,221,917
-
Put/Call ratio
-
107%
-
Price per share
-
$277.40
-
Number of holders
-
615
-
Value change
-
-$56,344,089
-
Number of buys
-
297
-
Number of sells
-
289
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q3 2019
As of 30 Sep 2019 REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) had 615 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 73,531,027 shares of stock of the company.
Largest 10 holders included Capital World Investors, BlackRock Inc., VANGUARD GROUP INC, HARRIS ASSOCIATES L P, LOOMIS SAYLES & CO L P, STATE STREET CORP, FMR LLC, ALLIANCEBERNSTEIN L.P., WELLINGTON MANAGEMENT GROUP LLP, and POLEN CAPITAL MANAGEMENT LLC.
This table shows 616 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.